174 related articles for article (PubMed ID: 19251665)
1. Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds.
Kampa KM; Acoba JD; Chen D; Gay J; Lee H; Beemer K; Padiernos E; Boonmark N; Zhu Z; Fan AC; Bailey AS; Fleming WH; Corless C; Felsher DW; Naumovski L; Lopez CD
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4390-5. PubMed ID: 19251665
[TBL] [Abstract][Full Text] [Related]
2. ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth.
Vives V; Su J; Zhong S; Ratnayaka I; Slee E; Goldin R; Lu X
Genes Dev; 2006 May; 20(10):1262-7. PubMed ID: 16702401
[TBL] [Abstract][Full Text] [Related]
3. New insights into the expanding complexity of the tumor suppressor ASPP2.
Kampa KM; Bonin M; Lopez CD
Cell Cycle; 2009 Sep; 8(18):2871-6. PubMed ID: 19657229
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
[TBL] [Abstract][Full Text] [Related]
5. Control of ASPP2/(53BP2L) protein levels by proteasomal degradation modulates p53 apoptotic function.
Zhu Z; Ramos J; Kampa K; Adimoolam S; Sirisawad M; Yu Z; Chen D; Naumovski L; Lopez CD
J Biol Chem; 2005 Oct; 280(41):34473-80. PubMed ID: 16091363
[TBL] [Abstract][Full Text] [Related]
6. ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.
Van Hook K; Wang Z; Chen D; Nold C; Zhu Z; Anur P; Lee HJ; Yu Z; Sheppard B; Dai MS; Sears R; Spellman P; Lopez CD
Biochem Biophys Res Commun; 2017 Jan; 482(4):1271-1277. PubMed ID: 27939881
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of apoptosis-stimulating protein two of p53 ameliorates acute kidney injury induced by ischemia reperfusion in mice through upregulation of autophagy.
Ji J; Zhou X; Xu P; Li Y; Shi H; Chen D; Li R; Shi H
J Cell Mol Med; 2019 Apr; 23(4):2457-2467. PubMed ID: 30675758
[TBL] [Abstract][Full Text] [Related]
8. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.
Suzuki A; de la Pompa JL; Stambolic V; Elia AJ; Sasaki T; del Barco Barrantes I; Ho A; Wakeham A; Itie A; Khoo W; Fukumoto M; Mak TW
Curr Biol; 1998 Oct; 8(21):1169-78. PubMed ID: 9799734
[TBL] [Abstract][Full Text] [Related]
9. Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure.
Schittenhelm MM; Illing B; Ahmut F; Rasp KH; Blumenstock G; Döhner K; Lopez CD; Kampa-Schittenhelm KM
PLoS One; 2013; 8(11):e80193. PubMed ID: 24312201
[TBL] [Abstract][Full Text] [Related]
10. ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy.
Lin M; Chang Y; Xie F; Shi Y; Pang L; Chen D
Dig Dis Sci; 2018 Jan; 63(1):146-154. PubMed ID: 29196956
[TBL] [Abstract][Full Text] [Related]
11. [Effect of overexpression of apoptosis-stimulating protein 2 of p53 on activation and apoptosis of hepatic stellate cells induced by transforming growth factor-β1 and its mechanism].
Lin MH; Guo XH; Qiao LX; Xie F; Shi Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):890-895. PubMed ID: 31941245
[No Abstract] [Full Text] [Related]
12. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
13. ASPP2: a gene that controls life and death in vivo.
Vives V; Slee EA; Lu X
Cell Cycle; 2006 Oct; 5(19):2187-90. PubMed ID: 16969108
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of apoptosis-stimulating protein two of p53 promotes liver regeneration in mice by activating mammalian target of rapamycin.
Shi H; Zhang Y; Ji J; Xu P; Shi H; Yue X; Ren F; Chen Y; Duan Z; Chen D
Sci Rep; 2018 Dec; 8(1):17927. PubMed ID: 30560875
[TBL] [Abstract][Full Text] [Related]
15. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
16. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2).
Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E
J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
Lossos IS; Natkunam Y; Levy R; Lopez CD
Leuk Lymphoma; 2002 Dec; 43(12):2309-17. PubMed ID: 12613517
[TBL] [Abstract][Full Text] [Related]
18. ASPP2 involvement in p53-mediated HIV-1 envelope glycoprotein gp120 neurotoxicity in mice cerebrocortical neurons.
Liu Z; Zang Y; Qiao L; Liu K; Ouyang Y; Zhang Y; Chen D
Sci Rep; 2016 Sep; 6():33378. PubMed ID: 27625111
[TBL] [Abstract][Full Text] [Related]
19. Effect of Bcl11b genotypes and gamma-radiation on the development of mouse thymic lymphomas.
Yoshikai Y; Sato T; Morita S; Kohara Y; Takagi R; Mishima Y; Kominami R
Biochem Biophys Res Commun; 2008 Aug; 373(2):282-5. PubMed ID: 18558082
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of apoptosis-stimulating protein 2 of p53 protects mice from acute hepatic injury induced by CCl
Xu P; Yao J; Ji J; Shi H; Jiao Y; Hao S; Chen D; Shi H
Toxicol Lett; 2019 Nov; 316():85-93. PubMed ID: 31513885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
